Corazon (corsee) D. Sanders - 29 Jun 2021 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role: Director
Signature: /s/ Karah Parschauer, attorney-in-fact
Issuer symbol: RARE
Transactions as of: 29 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 30 Jun 2021, 19:58:18 UTC
Previous filing: 21 Jun 2021
Next filing: 06 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RARE	Common Stock	Award	$0	+3,895		$0.000000	3,895	29 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RARE	Stock Option (Right to Buy)	Award	$0	+7,255		$0.000000	7,255	29 Jun 2021	Common Stock	7,255	$96.29	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/3rd of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the third anniversary of the grant date.
F2	The option shall vest with respect to 1/36th of the shares monthly such that the option shall fully vest on the third anniversary of the grant date.